Inhaler Apparatus - EP1646417

The patent EP1646417 was granted to Cipla EU on Dec 5, 2018. The application was originally filed on Jul 13, 2004 under application number EP04743399A. The patent is currently recorded with a legal status of "Revoked".

EP1646417

CIPLA EU
Application Number
EP04743399A
Filing Date
Jul 13, 2004
Status
Revoked
May 12, 2023
Grant Date
Dec 5, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

CHIESI FARMACEUTICIAug 8, 2019ADMISSIBLE

Patent Citations (21) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP0308524
DESCRIPTIONUS4972830
DESCRIPTIONUS5069204
INTERNATIONAL-SEARCH-REPORTUS2002104532
INTERNATIONAL-SEARCH-REPORTUS2002195102
INTERNATIONAL-SEARCH-REPORTUS4972830
INTERNATIONAL-SEARCH-REPORTUS5069204
INTERNATIONAL-SEARCH-REPORTUS5349945
INTERNATIONAL-SEARCH-REPORTUS6405727
INTERNATIONAL-SEARCH-REPORTWO9324167
OPPOSITIONEP0414536
OPPOSITIONUS2002104532
OPPOSITIONUS2002195102
OPPOSITIONUS4664107
OPPOSITIONUS4972830
OPPOSITIONUS5069204
OPPOSITIONUS5349945
OPPOSITIONUS6405727
OPPOSITIONWO2004028608
OPPOSITIONWO9324167
OPPOSITIONWO9949916

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents